Investing in small-cap health care companies can be tricky, with stocks that can soar or crash based on the results of a single clinical trial. However, equities.com's Small-Cap Stars, our proprietary list of small-cap companies with characteristics we've found to be most predictive of future success, isolates those companies that are best positioned to succeed.
Here are today's top performing health care Small-Cap Stars:
Organovo (ONVO)
Organovo gained 5.36% to $8.06. The gains came on a volume of 6,124,790 shares against an average daily volume of 1,777,497 shares. Organovo has had a trading range from $13.65 to $4.43 over the last year, it has a 50-day SMA of $7.43, and a 200-day SMA of $8.29.
Organovo Holdings Inc is a development-stage company. It is engaged in developing and commercializing functional human tissues.
Provectus Biopharmaceuticals Inc. (PVCT)
Provectus Biopharmaceuticals Inc. gained 3.39% to $0.91. The gains came on a volume of 633,785 shares against an average daily volume of 1,449,927 shares. Provectus Biopharmaceuticals Inc. has had a trading range from $6.03 to $0.30 over the last year, it has a 50-day SMA of $1.24, and a 200-day SMA of $1.65.
Provectus Biopharmaceuticals Inc is a development-stage pharmaceutical company. It develops, licenses, and sells pharmaceutical products for oncology and dermatology indications.
Therapeuticsmd (TXMD)
Therapeuticsmd gained 2.35% to $4.80. The gains came on a volume of 1,366,560 shares against an average daily volume of 2,743,645 shares. Therapeuticsmd has had a trading range from $9.01 to $2.03 over the last year, it has a 50-day SMA of $4.41, and a 200-day SMA of $5.04.
TherapeuticsMD Inc is a specialty pharmaceutical company. It develops and markets branded prescription, generic prescription, and over-the-counter (non-prescription) products exclusively for women.
Anacor Pharmaceuticals Inc. (ANAC)
Anacor Pharmaceuticals Inc. gained 2.3% to $17.34. The gains came on a volume of 400,987 shares against an average daily volume of 585,216 shares. Anacor Pharmaceuticals Inc. has had a trading range from $23.07 to $6.70 over the last year, its P/E ratio is 10.4, it has a 50-day SMA of $16.05, and a 200-day SMA of $16.54.
Anacor Pharmaceuticals Inc is engaged in the discovery, development and commercialization of novel small molecule therapeutics derived from its novel boron chemistry platform.
Biolase Inc (BIOL)
Biolase Inc gained 1.83% to $2.22. The gains came on a volume of 630,459 shares against an average daily volume of 434,711 shares. Biolase Inc has had a trading range from $3.87 to $1.14 over the last year, it has a 50-day SMA of $1.98, and a 200-day SMA of $2.22.
Biolase Inc is a biomedical company that develops, manufactures, and markets lasers in dentistry and medicine and also markets and distributes dental imaging equipment.
Equities.com's Health Care Small-Cap Stars - Helping You Build a Healthier Portfolio
No one can predict precisely which potential treatments will fly through their clinical trials and which will stumble along the way. At least, if someone can, they're undoubtedly spectacularly wealthy right now. But, while the science is clearly the most important factor for the success of a small-cap biotech company, it's not the only one.
Equities.com's Small-Cap Stars system uses a complicated statistical regression to determine which fundamental factors previous success stories had in common and then identifies those present health care small caps that share those traits. For health care companies, we found that a high enterprise value, a strong value line beta, and a high rate of reinvestment were among the most important qualities in predicting the potential success of a company.
All data provided by quotemedia and was accurate as of 4:30 pm ET.